EP300 and neoplasm: Immunohistochemical analysis revealed that EP300-AS1 knockdown increased PRMT5 and Ki67-positive cell number without affecting PTBP1 levels, supporting the tumor-suppressive role of EP300-AS1 (Fig. 6b).